When was Vivodyne founded?

Vivodyne was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Vivodyne located?

Vivodyne is headquartered in Philadelphia, United States.

Which legal entities is Vivodyne associated with?

Vivodyne is associated with VIVODYNE, INC..

How many employees does Vivodyne have?

As of Feb 28, 2026, the latest employee count at Vivodyne is 40.

Is Vivodyne a funded company?

Vivodyne is a funded company, having raised a total of $118M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 11, 2021.

How much is Vivodyne worth?

The latest valuation of Vivodyne is $***** as of Dec 02, 2022.

When was the latest funding round of Vivodyne?

Vivodyne's latest funding was a $***** Series A round on Feb 03, 2025, with participation from 8 investors.

Where does Vivodyne rank among its competitors?

Vivodyne ranks 6th amongst 91 active competitors, of which 36 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Pandorum, which secured $18M in Nov, 2025.

Who are the top competitors of Vivodyne?

Vivodyne's top competitors include InSphero, Ncardia and Pandorum. Among them, Pandorum secured the most recent funding round in November, 2025.

Vivodyne - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of AI-based platform for lab-grown human tissues. The company's platform culture human tissue models for drug discovery and utilizes single-cell 4D phenomics with an integrated confocal microscope. Also, has an automated robotic system that discovers drugs and cellular therapies.

Website: www.vivodyne.com/
Social
Email ID: *****@vivodyne.com

Key Metrics

Founded Year

2021

Location

Philadelphia, United States

Stage

Series A

Total Funding

$118M in 3 rounds

Latest Funding Round

Series A, Feb 03, 2025, $*****

Post Money Valuation

$***** as on Dec 02, 2022

Investors

Khosla Ventures & 7 more

Ranked

6^th among 91 active competitors

Employee Count

40 as on Feb 28, 2026

Similar Companies

InSphero & 64 more

View Vivodyne's full profile

Vivodyne is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VIVODYNE, INC. CIN: 4157677 , United States, Active	Nov 16, 2020	-	-	-

Vivodyne has raised a total funding of $118M over 3 rounds. Its first funding round was on Mar 11, 2021. Its latest funding round was a Series A round on Feb 03, 2025 for $*****. 8 investors participated in its latest round. Vivodyne has 8 institutional investors.

Here is the list of recent funding rounds of Vivodyne:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 03, 2025	2151804	Series A	7818297	9234846	7148723	6358151
Nov 22, 2023	2974784	Seed	6675432	7245874	1081307	Kairos Ventures & 3 more
Mar 11, 2021	1654251	Seed	6335641	5229077	4490350	8380781

Access funding benchmarks and valuations. Sign up today!

View details of Vivodyne's funding rounds and investors

The founders of Vivodyne is Dan Huh.

Here are the details of Vivodyne's key team members:

Dan Huh: Co-Founder of Vivodyne.

View details of Vivodyne's Founder profiles and Board Members

Vivodyne's employee count trend

Vivodyne has 40 employees as of Feb 26. Here is Vivodyne's employee count trend over the years:

Uncover Vivodyne's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vivodyne include InSphero, Ncardia and Pandorum. Here is the list of Top 10 competitors of Vivodyne, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	InSphero 2009, Schlieren (Switzerland), Series D	Developer of cell based assays for drug screening	$35M	Redalpine, ZEISS & 8 others	62/100
2nd	Ncardia 2011, The Hague (Netherlands), Series C	Company offering hiPSC based products and services for drug discovery and development	$77.4M	Epimede, Vesalius Biocapital Partners & 9 others	62/100
3rd	Pandorum 2011, Bengaluru (India), Series B	Developer of regenerative medicine and 3D tissues	$56.2M	PROTONS CORPORATE SERVICES, Indian Angel Network ... & 77 others	61/100
4th	Parallel Bio 2020, Cambridge (United States), Series A	Limited information available	$25.4M	Refactor Capital, AIX Ventures & 8 others	58/100
5th	NEXEL 2012, Seoul (South Korea), Series B	Provider of induced pluripotent stem cell (iPSC)-derived cells and organoids	$27M	SL Investment, KBD Capital & 10 others	55/100
6th	Vivodyne 2021, Philadelphia (United States), Series A	Developer of AI-based platform for lab-grown human tissues	$118M	Khosla Ventures, MBX Capital & 6 others	56/100
7th	Mestastop 2018, Bengaluru (India), Seed	Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics	$1.29M	IKP Knowledge Park, IIMA Ventures & 33 others	54/100
8th	FluidForm Bio 2017, Waltham (United States), Funding Raised	Developer of 3D bioprinting solutions for engineered tissues	-	HHS	52/100
9th	OncoPrecision 2020, Cordoba (Argentina), Seed	Developer of personalized assays for oncology precision therapy	$4.2M	Creative Ventures, SOSV & 4 others	51/100
10th	HeartBeat 2021, Vienna (Austria), Seed	Developer of stem-cell derived organoid models for cardiac drug discovery	$6.58M	aws Grunderfonds, Tensor Ventures & 3 others	50/100